Biosimilars

The AJMC® Biosimilars compendium is a comprehensive resource for news and expert insights into these biological products, including clinical research, patent and legal news, and regulatory updates.

Latest News

FDA logo and website | Image credit: Postmodern Studio - stock.adobe.com
FDA Q&A: Addressing Biosimilar Safety, AI in Drug Development, and Supply Chain Challenges

November 6th 2024

In a Q&A, an FDA spokesperson discusses efforts to reduce misinformation about biosimilars through education, the agency’s collaboration with global regulators to streamline development, and its work to address drug shortages while emphasizing safety, efficacy, and public trust.

Retinal condition  | Image Credit: Yakobchuk Olena - stock.adobe.com
Biosimilar Aflibercept P041 as Effective, Safe as Originator in nAMD

October 30th 2024

health policy chart | Image credit: JOURNEY STUDIO7 - stock.adobe.com
Exploring the Complexities of Biosimilars and Interchangeability

October 30th 2024

Cost of health care  | Image Credit: Scott Hales - stock.adobe.com
Biosimilars Expand Access and Reduce Costs in Oncology, Immunology

October 28th 2024

Market share increase | Image Credit: Kiattisak - stock.adobe.com
Samsung Bioepis Reports 2024 Biosimilar Market Growth Trends

October 15th 2024

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo